Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
E

Improper Labeling of Insulin, Liquid Protein, and Tuberculin Solution

Carlisle, Pennsylvania Survey Completed on 02-11-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to ensure medications and biologicals were properly labeled in accordance with facility policy and accepted professional standards. The facility’s Medication Labeling and Storage policy, dated February 2023, required that medication labels include, at a minimum, the medication name, prescribed dose, strength, expiration date when applicable, resident’s name, route of administration, and appropriate instructions and precautions. The policy also required that multi-dose vials opened or accessed be dated and discarded within 28 days unless otherwise specified by the manufacturer. Reference materials indicated that Novolog (insulin aspart) should be used or discarded within 28 days of opening, Medline Liquid Active Protein should be used or discarded within three months of opening, and tuberculin skin testing solution (Aplisol) expires 30 days after initial puncture. During observation of the Faith Short medication cart with an LPN, surveyors found an opened Novolog insulin FlexPen with approximately 200 units remaining, no resident name on the pen, and no date indicating when it was opened; the LPN confirmed that about 100 units were missing and that she did not know which resident it belonged to, when it was opened, or when it would expire. On the Love 1 medication cart, an LPN and surveyors observed an open stock bottle of liquid protein without an open date, and the LPN confirmed he would not know when it would expire. In the Faith Wing medication room, surveyors and an LPN observed an opened vial of Aplisol tuberculin testing solution with no open date on the vial, and the LPN confirmed she would not know when it would expire. In an interview, the DON confirmed the expectation that medications be labeled properly. These observations demonstrated noncompliance with the facility’s own policy and applicable state regulations regarding medication labeling and storage.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙